1. Annon., 1999. Note for Guidance on Quality of Modified Release Products. Oral dosage forms and Transdermal dosage forms, Section 1 (Quality). The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation (EMEA), London, July, 1999.
2. Castellanos, E., Iraizoz, A., Héctor, M., Alemán, A., Lara, L., Urribarri, E., Jordán, G., 2004. Matrix system for controlled release of drugs, using dextran, HPMC and cetyl alcohol. Cuban Patent CU22998, No. 2348/2004.
3. Effect of formulation variables on dissolution profile of diclofenac sodium from ethyl and hydroxypropyl methylcellulose tablets;Chattaraj;Drug Dev. Ind. Pharm.,1996
4. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanism and optimal performance;Colombo;PSTT,2000
5. Formulation, in-vitro release and therapeutic effect of hydrogels based controlled release tablets of propranolol hydrochloride;Ganga;Drug Dev. Ind. Pharm.,1992